What Fueled The Previous Growth In The Intranasal Drug Delivery Devices Market?
The intranasal drug delivery devices market has seen considerable growth due to a variety of factors.
• In recent years, the market size for intranasal drug delivery devices has seen robust growth. The market is projected to increase from $60.27 billion in 2024 to $65.59 billion in 2025, marking a compound annual growth rate (CAGR) of 8.8%.
This growth during the historical period can be credited to several factors including the uptick in chronic respiratory ailments, patient preference and adherence, ease of self-administration, usage in pediatric care, the boosted market scope in allergic rhinitis treatment, and a broader spectrum of indications.
How Does the Forecast Look for the Intranasal Drug Delivery Devices Market?
The intranasal drug delivery devices market is expected to maintain its strong growth trajectory in upcoming years.
• Anticipations project a sturdy expansion of the intranasal drug delivery devices market size in the approaching years. The market is projected to augment to $92.05 billion by 2029, growing at a compound annual growth rate (CAGR) of 8.8%.
This potential surge during the forecast period is believed to be due to factors such as the growing elder population, an upswing in global respiratory problems, broader applications in the field of neurological disorders, the emergence of personalized medicines, initiatives towards preventive healthcare and making forays into emerging economies. Key trends expected within the forecast period include the progression in formulation technologies, emphasis on applications in pediatric and geriatric sectors, enhancement in self-administration devices, the rise of nasal powder inhalers, and the inclusion of biologics and peptides.
What Are The Leading Drivers Of Growth In The Intranasal Drug Delivery Devices Market?
The rise in chronic illnesses is anticipated to be a significant driver of the intranasal drug delivery devices market's growth. These diseases are characterized by their long-term nature, requiring consistent medical care and often impacting daily activities. Intranasal drug delivery devices offer an effective, non-invasive method for managing these conditions, allowing for medication to be delivered directly to the affected region. This straightforward approach encourages quick absorption and ease of use. For instance, as per UK's National Health Service, in June 2024, the number of individuals in England at risk of developing type 2 diabetes had increased by almost 20% from 2022, reaching over 3.6 million. Hence, growing chronic disease prevalence supports the intranasal drug delivery devices market expansion. One of the key drivers behind the intranasal drug delivery devices market's growth is the surge in the need for non-invasive drug delivery. This approach involves delivering medicine into the body without piercing or cutting the skin or mucous membranes. Utilizing intranasal drug delivery devices makes the drug administration process simple and efficient, leveraging the large nasal blood vessel network for rapid absorption. This enhances drug bioavailability and patient compliance while minimizing application of invasive procedures. The American society for aesthetic plastic surgery reported a significant increase in non-surgical procedures like body contouring, skin treatment, toxins, and micro needing in the US in August 2023, with growth rates of 31%, 26%, 24%, and 23% respectively in 2022. As a result, the escalating demand for non-invasive drug delivery techniques fuels the growth of the intranasal drug delivery device market.
How Are The Segments Defined Within The Global Intranasal Drug Delivery Devices Market?
The intranasal drug delivery devices market covered in this report is segmented –
1) By Product: Powder Delivery Device, Liquid Delivery Device, Pressurized Metered-Dose Inhalers, Other Products
2) By Dosage: Unit-Dose, Multi-Dose
3) By Application: Chronic Obstructive Pulmonary Disease (COPD), Rhinitis, Cystic Fibrosis, Nasal Congestion, Asthma, Other Applications
4) By End User: Hospitals, Clinics, Homecare, Other End Users
Subsegments:
1) By Powder Delivery Device: Single-Dose Powder Device, Multi-Dose Powder Device
2) By Liquid Delivery Device: Single-Dose Liquid Device, Multi-Dose Liquid Device
3) By Pressurized Metered-Dose Inhalers (pMDIs): Breath-Actuated PMDIs, Conventional pMDIs
4) By Other Products: Gel Delivery Device, Nebulizers, Nasal Sprays
Pre-Book The Intranasal Drug Delivery Devices Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
What Emerging Trends Are Influencing The Growth Of The Intranasal Drug Delivery Devices Market?
Leading pharmaceutical firms in the nasal drug delivery technology market are focusing on coming up with innovative and enhanced products to offer their clientele alternative routes of drug administration, thus maintaining their market stronghold. One such example occurred in January 2023, when AptarGroup, Inc., a pharmaceutical and drug delivery business based in the US, introduced the first metal-free, recyclable, multidose nasal spray, APF Futurity. This was specifically designed to administer nasal saline and other similar over-the-counter (OTC) formulations. The APF Futurity spray, made from polyolefin materials, excludes any metallic elements or recycling disruptors, thereby eliminating the necessity for separation in recycling flows and encouraging a higher quality of recycled materials. The standout feature of this product is the design for recycling; it's an highly recyclable nasal spray pump, with a Class AA recycling streams certification from cyclos-HTP in Europe.
Who Are the Key Players In The Intranasal Drug Delivery Devices Market?
Major companies operating in the intranasal drug delivery devices market report are:
• Johnson and Johnson Inc.
• Merck and Co.Inc.
• Novartis AG
• AstraZeneca plc.
• GlaxoSmithKline PLC
• 3M Company
• Becton
• Dickinson and Company
• Teva Pharmaceutical Industries Ltd.
• AptarGroup Inc.
• West Pharmaceutical Services Inc.
• Teleflex Incorporated
• Recipharm AB
• Nemera Development S.A.
• Consort Medical plc.
• Vectura Group PLC
• Douglas Pharmaceuticals Ltd.
• Avanir Pharmaceuticals
• OptiNoset Inc.
• Flamel Technologies
• Aegis Therapeutics LLC
• Sonoma Pharmaceuticals
• PendoPharm Inc.
• Kurve Technology Inc.
• Impel NeuroPharma
• Impexium Medical Products
• B.F. Ascher and Company Inc.
• ENT Technologies Pty. Ltd.
• Neurelis Inc.
• Generex Biotechnology Corporation
What Is The Most Dominant Region In The Intranasal Drug Delivery Devices Market?
North America was the largest region in the intranasal drug delivery devices market in 2024. The regions covered in the intranasal drug delivery devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
